Full Text
SA34 Real-World Treatment Outcomes Among Relapsed/Refractory Patients with Mantle Cell Lymphoma Treated with Ibrutinib or Acalabrutinib

Abstract

Authors

S. Crawford M.H Lafeuille B. Emond D. Harb R. Voladarsky N. Chen S. Karve

Back to Volume 26, Supplemental Issue 6S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×